Stock listing

A41CNR Stock Price, News, Filings & Events — Imunon, Inc.

Selected listing: A41CNR · LSX · EUR · DE

A41CNR:LSX is the public stock listing for Imunon, Inc. The company focuses on developing innovative therapies for cancer treatment, leveraging its proprietary technology platforms. Recent news highlights advancements in their clinical trials and ongoing efforts to expand their product pipeline. Investors can find relevant filings and upcoming events that may impact the company's market position.

A41CNR:LSXEURDEUpdated July 24, 2026
Imunon, Inc. logo
Ticker
A41CNR:LSX
Asset type
Stock
Market cap
$6.3M
Sector
Health Technology
Industry
Biotechnology
Exchange
LSX
Currency
EUR

Imunon, Inc. A41CNR:LSX stock context

A41CNR:LSX is the public stock listing for Imunon, Inc. The company focuses on developing innovative therapies for cancer treatment, leveraging its proprietary technology platforms. Recent news highlights advancements in their clinical trials and ongoing efforts to expand their product pipeline. Investors can find relevant filings and upcoming events that may impact the company's market position.

Research Imunon, Inc.

Alternate listings